pCPA File Number: 21561
Under consideration for negotiation
in combination with azacitidine for the treatment of patients with newly diagnosed acute myeloid leukemia (AML) who are 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.
CADTH Project Number:
pCPA Engagement Letter Issued:
Negotiation Process Concluded: